in June 2021 ZonMw announced which 7 consortia could start within the PSIDER program in. Radboudumc researchers were part of these 7 consortia. With a total budget of 3.5 to 4 million, the consortia will work together in a multidisciplinary setting for the next 5 to 6 years. They all will contribute to either the creation of alternatives to embryos or the development of knowledge about disease mechanisms and the treatment of serious hereditary disorders.
Our researchers receive ZonMw funding for PSIDER program are:
- Michiel Vermeulen and Klaas Mulder from Faculty of Science of Radboud University and is part of the interfaculty research institute RIMLS.
- Title: From pluripotent stem cells to prime editing gene therapy for inherited cardiomyopathies (link)
- Nael Nadif Kasri (Radboud University)
- Title: BRAINMODEL: standardized, IPSC-based medicine for immediate application in monogenic neurodevelopmental disorders
Related news items
Nijmegen literally puts Digital Health on the map Flourishing ecosystem gets its own interactive overview22 July 2021
Digital Health is thriving in the Nijmegen region, where it contributes to better care and health and also creates jobs. To bring developers and end users even closer together, The Economic Board and the Radboudumc are introducing the Interactive Digital Health map.read more
Michiel Vermeulen and Klaas Mulder receive funding from ZonMw for a collaborative project using stem cell-based models15 July 2021
Michiel Vermeulen and Klaas Mulder, theme Cancer development and immune defense, receive funding from ZonMw for a collaborative project to develop a stem cell based model to study early human embryogenesis.read more
Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development15 July 2021
The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiative (IMI), a public-private European Research & Development Consortiumread more